MS PHARMA’s Post

Global biopharmaceutical company Takeda recently hosted the event “Innovation and Hope: Connecting Minds to Transform HAE Patient Care” in the region, uniting healthcare professionals to discuss innovative therapies and collaborative strategies for managing Hereditary Angioedema (HAE) in the Middle East. Read More: https://lnkd.in/deCUXYGr “We take pride in bringing together healthcare professionals and patient advocates for ‘Innovation and Hope: Connecting Minds to Transform HAE Patient Care’. It highlighted our commitment to enhancing the diagnosis and treatment of Hereditary Angioedema in the UAE. Through fostering collaboration and sharing advancements in care, we aim to improve health outcomes for patients and their families,” said, Ahmed Fayed, General Manager, Takeda East Gulf and Levant Cluster #MedEdgeMEA #HAE #PatientCare #InnovativeTherapies #Takeda #HealthcareLeadership #MiddleEastHealthcare #MedicalInnovation Professor Mohamed Abuzakouk Christophe Weber

In a rapidly evolving pharmaceutical landscape, events like CPHI Milan 2024 offer unparalleled opportunities for growth, visibility, and strategic alliances. Recently, Alisha Shinde, CEO of Marketaa Plus, attended this prestigious event—one of the largest gatherings in the pharma industry—bringing Marketaa Plus’s industry expertise and commitment to innovation center stage. For Marketaa Plus, a specialized marketing agency dedicated to the pharma sector, attending CPHI Milan went beyond networking; it was a pivotal moment to showcase their 360-degree marketing expertise, build new partnerships, and stay at the forefront of industry trends. Through this experience, Marketaa Plus Solutions Pvt Ltd solidified its role as a leading provider of compliant, results-driven marketing solutions tailored for the pharmaceutical industry. Discover why CPHI Milan 2024 was a game-changer for Marketaa Plus and how they continue to elevate their clients' visibility and impact in the competitive pharma landscape. Read more on Marketaa Plus’s www.marketaaplus.com latest blog insights: https://lnkd.in/dgCViJPT #CPHIMilan2024 #PharmaMarketing #PharmaceuticalIndustry #PharmaTrends #HealthcareMarketing #CPHI #NetworkingEvent #AlishaShinde #GlobalPharmaEvent #360Marketing #DigitalMarketing #MarketingInnovation #LifeSciencesMarketing #WomenInLeadership #CEOInsights #LeadershipInPharma #PharmaTrends2024 #LifeSciences #HealthTech #MarketaainMilan

📢 Weekly Top 5 Must-Read News in Market Access Today | 06- 12 January Highlights in Life Sciences! Welcome to 06- 12 January of our weekly newsletter series, where we bring you the most critical updates in market access, healthcare, and pharmaceuticals! Each week, we’ll highlight the top 5 stories making waves in the industry. Stay informed on these pivotal developments with our weekly insights—and don't miss future issues to keep up with everything happening in health sciences! Explore the full articles through the links below: 1️⃣ FDA Approves TRYNGOLZA™: First Treatment for Familial Chylomicronemia Syndrome: https://lnkd.in/d74Y2iUV 2️⃣ UAE Private Healthcare Embraces Biosimilars to Cut Costs and Boost Access: https://lnkd.in/dVCCspgX 3️⃣ EFPIA Advocates for Comprehensive Clinical Outcome Inclusion in EU Assessments: https://lnkd.in/dmT82yZz 4️⃣Digemid Launches New Journal on Pharmaceutical Regulation: https://lnkd.in/dKHnrdfz 5️⃣Inogen Launches SIMEOX 200 Airway Device Following FDA Approval: https://lnkd.in/db-NmMNq

🎤Looking forward to delivering another series of Investor Briefings, this time covering companies in the scope of our Generic & Biosimilar Medicine Programme! Institutional investors who are signatories of the Access to Medicine Foundation are invited to join us to delve into the latest insights on expanding access to medicines in LMICs.   The Foundation’s recently established Generic and Biosimilar Medicines Programme assesses what companies in this sector are doing to expand access to essential medicines in LMICs.   In these briefings, I will translate our assessments into insights valuable to the investor community. If you're invested in Hikma, Teva, Viatris, Cipla or Sun Pharma, you won't want to miss this!   🗓️ Info on dates and registrations can be found in our latest investor bulletin ➡ https://lnkd.in/ebHFru2C 💻Format: online ⏳ Duration: 30 minutes   If you have any questions, please don't hesitate to reach out.   #investing #ImpactInvesting #ResponsibleInvesting #ESG #AccesstoMedicine #EquitableAccess #AccesstoHealthcare #HealthcareEquity #GlobalHealth Suzanna van Es Twinelle B.

We are honored to introduce the third group of distinguished speakers who will enrich our discussions at this landmark event. These leaders are driving innovation and transformation across healthcare, pharmaceuticals, and digital technology in the region: 1️⃣ Dr. Gamal El-Leithy Chairman & CEO, Future Pharmaceutical Industries (FPi) | Head, Pharmaceutical Chamber, Federation of Egyptian Industries – Shaping the future of pharmaceutical innovation and industry leadership. 2️⃣ Prof. Dr. Aiman S. El Khatieb Vice President, Egyptian Drug Authority – Enhancing regulatory frameworks for pharmaceutical excellence and innovation. 3️⃣ Eng. Mahmoud Badawi Advisor to the Minister on Digital Transformation Affairs, Ministry of Communications and Information Technology (MCIT), Egypt – Pioneering digital transformation in healthcare for a more connected and efficient system. 4️⃣ Dr. Hesham Badr Vice President, Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management – Streamlining healthcare procurement for better access and efficiency. These speakers will explore pivotal themes, including innovations in pharmaceutical manufacturing, the impact of digital transformation on healthcare delivery, and strategies for enhancing access to medical technologies through unified procurement frameworks. 📅 Join us on December 14, 2024, for the ACCESS Health MENA Contemporary Healthcare Dialogues, where thought leaders and practitioners come together to redefine healthcare for the region. 📍 Cairo, Egypt | Livestream link in the comments #HealthcareInnovation #DigitalTransformation #PharmaceuticalLeadership #MENAHealthcare #GlobalHealthSystems

🌟 Privilaged to share my insights on Ai in healthcare at CPHI Saudi Arabia Today!🌟 Why email marketing is still a powerful tool in a marketers arsenal! On the sides at #cphi #cphimena #vision2030 #ai #healthcare #saudiarabia #aiinhealthcare Saudi pharmaceutical industry is at a pivotal moment, its a where the fusion of digital innovation and healthcare can truly enhance outcomes for patients and stakeholders alike. 🚀

 Agon at CPHI Middle East in Riyadh, Saudi Arabia! We were honored to participate in this transformative event, engaging with partners, industry leaders, and new connections to shape the future of healthcare and pharmaceuticals.  Watch Our Video! Experience the highlights of Agon’s journey at CPHI Middle East! From inspiring panel discussions to meaningful connections, witness the energy and innovation that drove this incredible event. Click below to watch!  Panel Discussions We Were Honored to Join:  Pharmaceutical Localization and Sustainable Access to High-quality Healthcare  This panel focused on strategies to enhance local pharmaceutical manufacturing and ensure sustainable access to quality healthcare products.  Speakers: Yara Almouti Amgad Talaat Fahad AlButhi Ashraf Al Grain  Regional Spotlight – Oman  A deep dive into Oman’s pharmaceutical potential, highlighting regional advancements and opportunities in healthcare.  Speakers: Yara Almouti Hamid Saif Al-Sabahi Sofie Tolk Damith D.  Scaling Up Digital Innovation: Revolutionizing R&D to Patient Care within the Pharma Industry (CME Accredited)  Discussed cutting-edge digital innovations transforming the journey from R&D to patient care in the pharma industry.  Speakers: Yara Almouti Dr Nadia Cheaib Abdulaziz Alhomod MD, MS, FACEP, FAMIA @GloriaLam  Paving the Way for Young Pharmacists to Enter the Pharmaceutical Industry: Building Capacity and Incentive Programs (CME Accredited)  Explored initiatives to empower young pharmacists through capacity-building programs and industry incentives.  Speakers: Yara Almouti Vivien Santillan Dr Nadia Cheaib Venus Elrayes  We extend our deepest gratitude to everyone who made this event a success, Together, we are paving the way for a brighter future in healthcare! #AgonAtCPHI #CPHIMiddleEast #PharmaInnovation #PharmaLeaders #SustainableHealthcare #DigitalTransformation #R&DEvolution #YoungPharmacists #PharmaNetworking #RiyadhEvents #PharmaLocalization #FutureOfHealthcare #AgonPharma #PharmaLeadership #GlobalHealthcare #HealthcareInnovation #LifeSciences #PharmaTrends #PharmaEvent #HealthcareLeaders #PharmaGrowth #CPHISaudiArabia #PharmaceuticalDevelopment #PharmaOpportunities #GlobalNetworking #AgonWorldwide #BetterHealthcare #EmpoweringPharmacists #InnovativePharma #MiddleEastPharma #PharmaIndustryEvents

Yesterday we launched the 2024 Access to Medicine Index #ATMI24 which provides an in-depth analysis of what the #pharma industry is doing to bridge the gap in hashtag #EquitableAccess. The report shows an overall stagnation in pharmaceutical companies’ efforts to improve access to essential healthcare products across low- and middle-income countries #LMICs. While some modest progress has been made, the potential for improving access is still far from realised and the pace of change is slow. It also includes three key findings: 👉 Pharma companies are taking steps to address access in low-income countries, but significant gaps remain  👉 Efforts to ramp up wider local availability of medicines through voluntary licensing and technology transfers are limited  👉 Patients in low- and middle-income countries largely left out of clinical trials, limiting access to new treatments The report is the culmination of two years work, massive kudos to the research team who helped to bring it together: Camille Romero Claudia Martínez Irene Pirrone Tarryn Davey OLY Sjors van Gijzel Charlotte Salgaard Nielsen Emma Shiffman Chloe Snowdon Aishwarya Ashok Dr.Swati J. #ATMI24 #AccesstoMedicine #HealthEquity #EquitableAccess #pharma

📌 EVENT | 20th BIOSIMILAR MEDICINES CONFERENCE by MFE 📆 April 18-19 📍 Hilton Amsterdam Airport Schiphol    ▶ Join ASPHALION experts Lidia Cánovas, Inés Bargueño Gefaell and Petra Teresak, MSc, PhD next week at the 20th Biosimilar medicines conference by Medicines for Europe that will take place in Amsterdam!!    ▶ As patient demand for #biologicalmedicines increases, and to keep pace with changes in the #pharmaceutical and #healthcare landscapes, this edition of the conference aims to provide a meaningful opportunity to jump start the multistakeholder #policyprocess, ensuring the #European #policyframework and #Global #regulatorysystem secure more #biosimilarmedicines development and equitable access.    🤝🏻📧 Meet them in Amsterdam by sending an email to: info@asphalion.com    Reach us out for any regulatory need!  https://bit.ly/3Ug29cf    #MFE #RA #Biosimilars #EU #event #Regulation #RegulatoryAffairs #WeAreAsphalion #WeCare #KnowledgeFromExperience  

I was delighted to speak at the CPHI Middle East Pharma Summit 2024 in Riyadh, which took place from December 10th to 12th. The CPHI Middle East Pharma Summit brought together #industry leaders, #innovators, and #experts to discuss the latest trends and advancements in the #pharmaceutical sector. Here are some key takeaways: 👉 #Innovation in Pharmaceuticals: The summit highlighted groundbreaking innovations in drug development, including advancements in biopharmaceuticals, vaccines, and genomics. These innovations are set to transform healthcare delivery and patient outcomes. 👉 #Regulatory and Compliance: There was a strong focus on the evolving regulatory landscape. Experts discussed the need for updated and harmonized regulatory frameworks to keep pace with rapid technological advancements, ensuring safety and efficacy in new treatments. 👉 #Digital Transformation: The role of digital health technologies was a major theme. Discussions centered on how digital tools, such as AI and machine learning, are being integrated into pharmaceutical processes to enhance efficiency and accuracy. 👉 #Supply Chain Resilience: The importance of building resilient and flexible supply chains was emphasized. The summit addressed strategies to mitigate disruptions and ensure the continuous supply of essential medicines. 👉 #Sustainability: Sustainability in pharmaceutical manufacturing and distribution was another key topic. The industry is increasingly focusing on reducing its environmental footprint through sustainable practices and green technologies. 👉 #Collaboration and Partnerships: The event underscored the importance of collaboration between pharmaceutical companies, healthcare providers, and technology firms. These partnerships are crucial for driving innovation and improving healthcare delivery. 👉 #Patient-Centric Approaches: There was a strong emphasis on patient-centric care, with discussions on how to better engage patients in their own health management and improve their overall experience. These takeaways reflect the summit's commitment to advancing the pharmaceutical industry through innovation, collaboration, and a focus on patient care in the Middle East and beyond. Thank you to CPHI Middle East and Informa Markets for organizing this valuable event and for the invitation. A special thanks to Agnès Maignien, Georgette Njeim, for the professional collaboration, and to all the participants for their engagement. CPHI Middle East #Pharma #connectivity #digitaltool #regulatorycompliance